文献速递眼底病与葡萄膜炎

自体血小板浓缩物在黄斑裂孔玻璃体切除术中的疗效:系统综述与Meta分析

THERAPEUTIC EFFECT OF USING AUTOLOGOUS PLATELET CONCENTRATE IN VITRECTOMY FOR MACULAR HOLE: A Systematic Review and Meta-Analysis.
PubMed 文献 · Retina · 2023-01-01

该系统综述与Meta分析纳入7项对照试验共634只眼,比较玻璃体切除术中使用自体血小板浓缩物(APC)与否对黄斑裂孔(MH)的疗效。结果显示APC显著提高MH闭合率(OR=5.34,95%CI 2.83-10.07,P<0.001),术后最佳矫正视力与对照组无显著差异(SMD=-0.07,95%CI -0.35至0.22,P=0.644),且未增加视网膜脱离或MH复发等并发症。作者认为APC在MH手术中有效且安全。

要点

  • APC组黄斑裂孔闭合率显著高于对照组(OR=5.34,95%CI 2.83-10.07,P<0.001)。
  • APC组与基线相似对照组的术后视力无显著差异(SMD=-0.07,95%CI -0.35至0.22,P=0.644)。
  • 使用APC未导致术后视网膜脱离或黄斑裂孔复发的额外并发症。

核心结论

  • 在玻璃体切除术中使用APC与更高的黄斑裂孔闭合率相关,且未增加并发症,作者认为其在黄斑裂孔手术中有效且安全。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Web of Science和Embase数据库,遵循PROSPERO方案(CRD42022366202),纳入比较玻璃体切除术中是否使用APC的对照试验,共纳入7项研究、634只眼。

主要发现

  • 使用APC显著提高玻璃体切除术中黄斑裂孔的闭合率(OR=5.34,95%CI 2.83-10.07,P<0.001)。
  • APC组与基线相似的对照组相比,术后视力无显著差异(SMD=-0.07,95%CI -0.35至0.22,P=0.644)。
  • 使用APC未导致术后视网膜脱离或黄斑裂孔复发的额外并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To summarize the current evidence regarding the therapeutic effect of using autologous platelet concentrate (APC) in vitrectomy for macular hole (MH). METHODS: The PubMed, Web of Science, and Embase databases were searched according to the PROSPERO protocol (CRD42022366202). Controlled trials comparing whether APC was used in the vitrectomy of MH were included. The primary outcome was the closure rate of MH and postoperative best-corrected visual acuity, and the secondary outcome was the incidence of different types of complications. RESULTS: Seven studies that included 634 eyes were eligible. For the primary outcome, the usage of APC significantly improved the closure rate of MH in vitrectomy (odds ratio [OR] = 5.34, 95% confidence interval, 2.83-10.07, P < 0.001). Postoperative visual acuity did not significantly differ between the APC group and similar baseline controls (SMD = -0.07, 95% confidence interval, -0.35 to 0.22, P = 0.644). For the secondary outcome, using APC did not result in additional complications regarding postoperative retinal detachment or the recurrence of MH. CONCLUSION: The use of APC in vitrectomy was associated with a superior closure rate of the hole and no additional complications; therefore, it is effective and safe in MH surgery.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Wang Y, Xu Z, Zhao X, et al. THERAPEUTIC EFFECT OF USING AUTOLOGOUS PLATELET CONCENTRATE IN VITRECTOMY FOR MACULAR HOLE: A Systematic Review and Meta-Analysis. Retina. 2023. PMID: 37607135. doi:10.1097/IAE.0000000000003888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。